Quadrant Capital »

Lexicon Pharmaceuticals shares owned by Quadrant Capital

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1k 1.4k 1.53

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Target Corporation (TGT)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for Quadrant Capital

Top funds holding Lexicon Pharmaceuticals

Artal Group
BVF
Vanguard Group
Jpmorgan Chase & Co
NEA Management Company
Gail Mannix
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
GSA Capital Partners
D. E. Shaw & Co
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Jane Street
Virtus ETF Advisers

View all funds holding Lexicon Pharmaceuticals